最新ニュース Corpay (NYSE:CPAY) 株価情報

CORPAY INC

Corpay

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.

Corpay Inc

Fidus Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDUS#NASDAQ">FDUS</a>) reported quarterly earnings of $0.54 per share which met the analyst consensus estimate. This is a 8.47 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $36.50 million which beat the analyst consensus estimate of $35.70 million by 2.26 percent. This is a 5.34 percent increase over sales of $34.65 million the same period last year.

Earnings

Earnings Beats

News

FDUS

Fidus Investment Q1 Adj. EPS $0.54, Inline, Sales $36.50M Beat $35.70M Estimate

Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) is looking for Q2 Adj EPS of $0.18 vs $0.19 analyst estimate. sees sales of $500.000 million-$501.000 million vs $500.34 million analyst estimate.

Guidance

Cloudflare Sees Q2 Adj EPS $0.18 vs $0.19 Est; Sees Sales $500.000M-$501.000M vs $500.34M Est

CVRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) lowers FY2025 sales outlook from $63.00 million-$65.00 million to $55.00 million-$58.00 million vs $61.43 million estimate.

CVRX

CVRx Lowers FY2025 Sales Guidance from $63.00M-$65.00M to $55.00M-$58.00M vs $61.43M Est

Astrana Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTH#NASDAQ">ASTH</a>) sees Q2 sales of $615.000 million-$655.000 million vs $660.68 million analyst estimate.

ASTH

Astrana Health Sees Q2 Sales $615.000M-$655.000M vs $660.68M Est

Cytek Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTKB#NASDAQ">CTKB</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 125 percent. This is a 80 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $51.93 million which beat the analyst consensus estimate of $42.66 million by 21.72 percent. This is a 15.76 percent increase over sales of $44.86 million the same period last year.

Earnings Misses

CTKB

Cytek Biosciences Q1 EPS $(0.09) Misses $(0.04) Estimate, Sales $51.93M Beat $42.66M Estimate

Serina Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SER#AMEX">SER</a>) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.61) by 19.67 percent. This is a 85.5 percent increase over losses of $(3.38) per share from the same period last year.

Serina Therapeutics Q1 EPS $(0.49) Beats $(0.61) Estimate

Super Group (SGHC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGHC#NYSE">SGHC</a>) raises FY2025 sales outlook from $2.04 billion to $2.12 billion vs $1.92 billion estimate.

SGHC

Super Group (SGHC) Raises FY2025 Sales Guidance from $2.04B to $2.12B vs $1.92B Est

WIIM

LYFT

Lyft shares are trading higher after the company announced a $750M share buyback plan

Peakstone Realty Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKST#NYSE">PKST</a>) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.61 by 1.64 percent. This is a 11.43 percent decrease over earnings of $0.70 per share from the same period last year. The company reported quarterly sales of $56.97 million which beat the analyst consensus estimate of $54.52 million by 4.49 percent. This is a 3.81 percent decrease over sales of $59.23 million the same period last year.

PKST

Peakstone Realty Q1 FFO $0.62 Beats $0.61 Estimate, Sales $56.97M Beat $54.52M Estimate

Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) is looking for Q1 GAAP EPS of $(0.15)-$(0.07) vs $(0.14) analyst estimate..

MCHP

Microchip Technology Sees Q1 GAAP EPS $(0.15)-$(0.07) vs $(0.14) Est

Universal Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UEIC#NASDAQ">UEIC</a>) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 36.84 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $92.33 million which beat the analyst consensus estimate of $91.97 million by 0.39 percent. This is a 0.46 percent increase over sales of $91.90 million the same period last year.

UEIC

Universal Electronics Q1 Adj. EPS $(0.12) Beats $(0.15) Estimate, Sales $92.33M Beat $91.97M Estimate

Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) is looking for Q1 Adj EPS of $0.18-$0.26 vs $0.16 analyst estimate. sees sales of $1.020 billion-$1.070 billion vs $987.62 million analyst estimate.

Microchip Technology Sees Q1 Adj EPS $0.18-$0.26 vs $0.16 Est; Sees Sales $1.020B-$1.070B vs $987.62M Est

Yelp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) widens FY2025 sales outlook from $1.47 billion-$1.49 billion to $1.47 billion-$1.49 billion vs $1.48 billion estimate.

YELP

Yelp Widens FY2025 Sales Guidance of $1.47B-$1.49B vs $1.48B Est

Astrana Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTH#NASDAQ">ASTH</a>) affirms FY2025 sales outlook from $2.50 billion-$2.70 billion to $2.50 billion-$2.70 billion vs $2.73 billion estimate.

Astrana Health Affirms FY2025 Sales Guidance of $2.50B-$2.70B vs $2.73B Est

Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) sees Q2 sales of $130.000 million-$140.000 million vs $136.82 million analyst estimate.

RKLB

Rocket Lab USA Sees Q2 Sales $130.000M-$140.000M vs $136.82M Est

EXPE

Expedia Group shares are trading lower after the company reported worse-than-expected Q1 sales results.

Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.17 by 5.88 percent. This is unchanged from the same period last year. The company reported quarterly sales of $479.09 million which beat the analyst consensus estimate of $469.28 million by 2.09 percent. This is a 26.54 percent increase over sales of $378.60 million the same period last year.

Cloudflare Q1 Adj. EPS $0.16 Misses $0.17 Estimate, Sales $479.09M Beat $469.28M Estimate

Buybacks

Lyft Announces $750M Share Buyback Plan

PODD

Insulet shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates. Also, the company issued Q2 sales guidance above estimates.

Yelp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.33 by 9.09 percent. This is a 80 percent increase over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $358.53 million which beat the analyst consensus estimate of $353.33 million by 1.47 percent. This is a 7.75 percent increase over sales of $332.75 million the same period last year.

Comments

Corpay

ニュース

最新ニュース Corpay (NYSE:CPAY) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル